You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

11 Results
Guidelines and Advice
Status: Archived
ID: 17-5
Jul 2016
Guidelines and Advice
Status: In-Review
ID: SCT 6
Feb 2016
Guidelines and Advice
Status: Current
ID: GL-C50-26
Feb 2016
Guidelines and Advice
Status: In-Review
ID: 12-9
Jan 2016
Guidelines and Advice
Status: Archived
ID: 12-16
Jun 2016
Cancer facts
Jun 2016
Cancer facts
Apr 2016
Statistical Reports
Jun 2016
Drug
Other Name(s): Sylvant®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Mar 2025
Regimen
Cancer Type:
Hematologic, 
Rare Diseases
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Siltuximab - Multicentric Castleman’s Disease (MCD)
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
siltuximab
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Mar 2025
Guidelines and Advice
Status: Archived
ID: 20-3
Jan 2016